radiation therapy (8.33, 0.005); MTHFR (8.33, 0.005); quality of life (8.28, 0.005); BRCA2 (6.31, 0.05); breast cancer (5.62, 0.05). This evidence concerns the gene MTHFR and breast carcinoma.